|
Real-time Estimate
Tradegate
11:57:49 18/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 14.86 EUR | -1.59% |
|
-0.27% | -41.72% |
| 11-17 | Formycon AG Names Tezspire And Hemlibra As Reference Drugs For Biosimilar Candidates FYB210 And FYB286 | CI |
| 11-12 | Formycon AG, Nine Months 2026 Earnings Call, Nov 12, 2026 |
Chart: Technical Analysis
XetraEUR
| Markets | Quality | ||
|---|---|---|---|
Xetra
| FYB | Delayed | |
| FYB | Real-time | ||
| FYBd | Real-time | ||
| FYB | Real-time | ||
| FYB | Delayed | ||
| 0W4N | Real-time | ||
| FYB | Delayed | ||
| FYB | End-of-day quote | ||
| FYB | End-of-day quote |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 17.28 | 18.3 | 19.92 |
| Spread/Res. | -13.66% | -18.47% | -25.10% |
| Spread/Supp. | +5.82% | +5.82% | +5.82% |
| Support | 14.1 | 14.1 | 14.1 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- FYB Stock
- Charts Formycon AG
Select your edition
All financial news and data tailored to specific country editions
















